Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

JOYY Chairman, Xiaomi Founder Plan to take JOYY Private, Firm Valued at $8 Billion USD

by Global Market Bulletin
August 27, 2021
in Stock Market News
0
JOYY Chairman, Xiaomi Founder Plan to take JOYY Private, Firm Valued at $8 Billion USD
40
SHARES
86
VIEWS
Share on FacebookShare on Twitter

In a story first reported by Reuters, three sources close to JOYY Inc (Nasdaq: YY)  and Xiamoi (HKG: 1810) in a deal that could value the firm at up to $8 Billion. JOYY’s top shareholders are Chairman David Li and Lei Jun, Xiamoi founder.

You might also like

5 Stocks With Billion-Dollar Potential You Should Not Miss

10 Stocks With Billion-Dollar Potential You Should Not Miss

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

The pair believe the Chinese company is undervalued in the market. JOYY had an average market value of $3.9 Billion recently while net assets totalled $5.6 Billion as of June 30th quarterly results.

JOYY was founded in 2005 and went public in 2012 on the Nasdaq markets. The company also runs game-focused social media platform Hago as well as a 16% ownership stake in Chinese streaming video game platform Huya (NYSE: HUYA).

Recent 6 month performance for JOYY has seen the shares down over 50%. The Nasdaq Golden Dragon China Index which tracks Chinese firms has dropped 40% in comparison.

The NASDAQ Golden Dragon China Index is a modified market capitalization weighted index comprised of companies whose common stock is publicly traded in the United States and the majority of whose business is conducted within the People’s Republic of China. 

The Index is designed to provide insight and access to the unique economic opportunities taking place in China while still providing the transparency offered with U.S. listed securities. 

The Index divisor was initially determined to yield a benchmark value of 2,500.00 at the close of trading on September 30, 2003. The NASDAQ Golden Dragon China Index was created by, and is a trademark of, Halter Financial Group.

Li and Lei respectively own a total of 31% of the company according to the JOYY Annual Report filings with Li holding a 76% voting power position.

Completion of the deal would add to a growing list of Wall Street listed Chinese companies that have opted out of continuing in the United States markets either through returning to Chinese markets or private takeovers.

As indicated in the Global Dragon China index, the moves come after increased scrutiny and auditing requirements for United States listed Chinese companies after political tensions have risen between the countries.

Reuters also reported last month that Weibo (Nasdaq: WB) Chairman Charles Chao and a state investor were in talks to take Weibo private in a deal that could value the Nasdaq-listed Chinese equivalent of Twitter at $20 billion-plus.

There were 16 announced take-private deals of U.S.-listed Chinese companies worth $19 billion last year, Dealogic data shows, versus just five such deals worth $8 billion in 2019.

The price target offering is rumored to be between the range of $75 – $100 per share, a 50-100% premium over the shares average price during the last 30 day trading period.

Tags: China Stocks
Share16Tweet10

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

5 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
0
5 Stocks With Billion-Dollar Potential You Should Not Miss

In this article, we will take a look at the 5 Stocks With Billion-Dollar Potential You Should Not Miss. For investors looking for the complete list, you can...

Read moreDetails

10 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
0
10 Stocks With Billion-Dollar Potential You Should Not Miss

In this article, we will take a look at the 10 Stocks With Billion-Dollar Potential You Should Not Miss. Wall Street ended the week caught between optimism and...

Read moreDetails

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

by Global Market Bulletin
July 18, 2026
0
Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

by Global Market Bulletin
July 18, 2026
0
Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • 5 Stocks With Billion-Dollar Potential You Should Not Miss
  • 10 Stocks With Billion-Dollar Potential You Should Not Miss
  • Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?